🟢 Lantern Pharma is trading 6.64% up in after-hours trading

Lantern Pharma is trading 6.64% higher at $0.70 after-hours, with no confirmed company-specific catalyst identified.

• The October 20 regular session closed at $0.66. The latest company press-release listing shows an October 7 announcement, not a new October 20 release.
• The broader market was mixed: the S&P 500 was up 0.3%, the Dow up 1%, and the Nasdaq down slightly; available evidence does not establish a market-wide explanation.
• After-hours trading volume was unavailable in the reviewed sources.